The Emirates News Agency reported that the expanded UAE-US healthcare cooperation will focus on joint initiatives in genomic research, digital health applications and specialised medical services to address shared health priorities. Senior officials from both sides reviewed progress on existing agreements while identifying opportunities for deeper collaboration in precision medicine. The discussions emphasised the role of advanced technologies in enhancing patient outcomes across populations.
According to the Department of Health Abu Dhabi, the Emirati Genome Program has sequenced nearly one million genomes, creating a major resource for international research partnerships. This dataset supports population-specific insights that can improve prevention, diagnosis and treatment strategies. The US cooperation will build directly on this foundation to accelerate biomedical advancements.
A strategic mission by the Department of Health Abu Dhabi to the United States earlier in 2026 produced multiple agreements with American entities, the department’s announcements show. These included memorandums with Novartis on genomics research and capacity building as well as with Mammoth Biosciences on gene-editing therapies for rare diseases. Such steps have positioned the UAE as an emerging hub for life sciences collaboration.
Digital health integration forms a central element of the expanded partnership, with both nations exploring AI-driven tools and data analytics, a PwC Middle East assessment of GCC digital transformation indicated. The framework aims to facilitate telemedicine, electronic records sharing and predictive health modelling. Specialised care cooperation will target areas including oncology, rare diseases and advanced therapeutics.
PharmExec analysis published in September 2026 noted a 300 percent rise in clinical trial activity in Abu Dhabi over the prior two years, reflecting an environment conducive to international partnerships. The latest UAE-US agreements are expected to further increase research output and knowledge exchange. Training programmes for medical professionals and joint studies are anticipated under the cooperation.
The Department of Health Abu Dhabi has pursued an integrated approach linking genomics, clinical data and AI within a unified system, its statements confirm. This model supports the bilateral efforts with the US by enabling real-world application of research findings. Ongoing engagements will continue to align regulatory standards and innovation priorities between the two countries.
